Alcohol, liver, systemic inflammation and skin: A focus on patients with psoriasis

Skin Pharmacology and Physiology

Volumn 26, Issue 3, 2013, Pages 119-126

  Farkas, A ^a   Kemeny L ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acetaldehyde; Acetone; Alcohol; Alcoholic liver disease; Psoriasis; Systemic inflammation

Indexed keywords

ALCOHOL; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; CELL PROLIFERATION; CORRELATIONAL STUDY; CYTOKINE RELEASE; DERMATITIS; DRUG DOSE COMPARISON; HUMAN; INFECTION RISK; KERATINOCYTE; KUPFFER CELL; LIVER FIBROSIS; LYMPHOCYTE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; REVIEW; TREATMENT OUTCOME; ALCOHOL ABUSE; AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE SEVERITY; GENERAL CONDITION DETERIORATION; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; INFLAMMATION; LIVER; LIVER FUNCTION; NONHUMAN; SKIN; SKIN FUNCTION; SYSTEMIC DISEASE;

ALCOHOLISM; ANIMALS; ETHANOL; HUMANS; INFLAMMATION; LIVER; PSORIASIS; SKIN;

EID: 84875640369     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000348865     Document Type: Review

References (74)

1. Nestle FO, Kaplan DH, Barker J: Psoriasis. N Engl J Med 2009; 361: 496-509.
2. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ: Skin immune sentinels in health and disease. Nat Rev Immunol 2009; 9: 679-691.
3. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ, Gilliet M: Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 2005; 202: 135-143. (Pubitemid 41002916)
4. Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M, Blauvelt A: Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 2009; 129: 2175-2183.
5. Szabo SK, Hammerberg C, Yoshida Y, Bata-Csorgo Z, Cooper KD: Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. J Invest Dermatol 1998; 111: 1072-1078. (Pubitemid 29115177)
6. Dika E, Bardazzi F, Balestri R, Maibach HI: Environmental factors and psoriasis. Curr Probl Dermatol 2007; 35: 118-135.
7. Higgins EM, du Vivier AW: Alcohol and the skin. Alcohol Alcohol 1992; 27: 595-602.
8. Higgins EM, du Vivier AW: Cutaneous disease and alcohol misuse. Br Med Bull 1994; 50: 85-98. (Pubitemid 24097033)
9. Zhu KJ, Zhu CY, Fan YM: Alcohol consumption and psoriatic risk: a meta-analysis of case-control studies. J Dermatol 2012; 39: 770-773.
10. McClain CJ, Cohen DA: Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989; 9: 349-351. (Pubitemid 19074964)
11. Lucey MR, Mathurin P, Morgan TR: Alcoholic hepatitis. N Engl J Med 2009; 360: 2758-2769.
12. Farkas A, Kemeny L: Psoriasis and alcohol: is cutaneous ethanol one of the missing links? Br J Dermatol 2010; 162: 711-716.
13. Tobin AM, Higgins EM, Norris S, Kirby B: Prevalence of psoriasis in patients with alcoholic liver disease. Clin Exp Dermatol 2009; 34: 698-701.
14. Uesugi T, Froh M, Arteel GE, Bradford BU, Wheeler MD, Gabele E, Isayama F, Thurman RG: Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol 2002; 168: 2963-2969. (Pubitemid 34211677)
15. Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG: Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001; 34: 101-108. (Pubitemid 32591488)
16. Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680. (Pubitemid 32747155)
17. Yin M, Bradford BU, Wheeler MD, Uesugi T, Froh M, Goyert SM, Thurman RG: Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 2001; 166: 4737-4742. (Pubitemid 32233762)
18. McMullen MR, Pritchard MT, Wang Q, Millward CA, Croniger CM, Nagy LE: Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 2005; 128: 2066-2076. (Pubitemid 40824714)
19. Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, Reiser J, Kolls JK: TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 2008; 181: 3049-3056.
20. Laso FJ, Iglesias MC, Lopez A, Ciudad J, San Miguel JF, Orfao A: Increased interleukin-12 serum levels in chronic alcoholism. J Hepatol 1998; 28: 771-777. (Pubitemid 28223480)
21. Gonzalez-Reimers E, Santolaria-Fernandez F, Medina-Garcia JA, Gonzalez-Perez JM, de la Vega-Prieto MJ, Medina-Vega L, Martin-Gonzalez C, Duran-Castellon MC: TH-1 and TH-2 cytokines in stable chronic alcoholics. Alcohol Alcohol 2012; 47: 390-396.
22. Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS: Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112: 917-920. (Pubitemid 20193676)
23. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI: Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13: 267-276.
24. Qin L, He J, Hanes RN, Pluzarev O, Hong JS, Crews FT: Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation 2008; 5: 10.
25. Gonzalez-Quintela A, Campos J, Loidi L, Quinteiro C, Perez LF, Gude F: Serum TNFalpha levels in relation to alcohol consumption and common TNF gene polymorphisms. Alcohol 2008; 42: 513-518.
26. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL: Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990; 14: 255-259. (Pubitemid 20153376)
27. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, Williams R: Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18: 41-46. (Pubitemid 23193615)
28. Neuman MG, Schmilovitz-Weiss H, Hilzenrat N, Bourliere M, Marcellin P, Trepo C, Mazulli T, Moussa G, Patel A, Baig AA, Cohen L: Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int J Hepatol 2012; 2012: 231210.
29. Tung KH, Huang YS, Yang KC, Perng CL, Lin HC, Lee SD: Serum interleukin-12 levels in alcoholic liver disease. J Chin Med Assoc 2010; 73: 67-71.
30. Laso FJ, Iglesias MC, Lopez A, Ciudad J, San Miguel JF, Orfao A: Increased interleukin-12 serum levels in chronic alcoholism. J Hepatol 1998; 28: 771-777. (Pubitemid 28223480)
31. McClain CJ, Cohen DA, Dinarello CA, Cannon JG, Shedlofsky SI, Kaplan AM: Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci 1986; 39: 1479-1485. (Pubitemid 16031644)
32. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ: Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 1992; 119: 547-552.
33. Hoek JB, Pastorino JG: Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002; 27: 63-68. (Pubitemid 34626486)
34. Dey A, Cederbaum AI: Alcohol and oxidative liver injury. Hepatology 2006; 43:S63-S74.
35. Wu D, Cederbaum AI: Oxidative stress and alcoholic liver disease. Semin Liver Dis 2009; 29: 141-154.
36. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, de Nadai P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O, Deviere J: The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009; 49: 646-657.
37. Casey CA, Nanji A, Cederbaum AI, Adachi M, Takahashi T: Alcoholic liver disease and apoptosis. Alcohol Clin Exp Res 2001; 25: 49S-53S. (Pubitemid 32545012)
38. Thurman RG, Bradford BU, Iimuro Y, Frankenberg MV, Knecht KT, Connor HD, Adachi Y, Wall C, Arteel GE, Raleigh JA, Forman DT, Mason RP: Mechanisms of alcohol-induced hepatotoxicity: studies in rats. Front Biosci 1999; 4:e42-e46.
39. Greijer AE, van der Wall E: The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004; 57: 1009-1014. (Pubitemid 39331346)
40. Matzinger P: The danger model: a renewed sense of self. Science 2002; 296: 301-305. (Pubitemid 34303674)
41. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, Mc-Clain CJ: Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 2007; 46: 823-830. (Pubitemid 47436129)
42. Fukui H, Brauner B, Bode JC, Bode C: Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991; 12: 162-169.
43. Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A: Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: relationship with ethanol intake and liver disease. Cytometry B Clin Cytom 2007; 72: 408-415. (Pubitemid 350194358)
44. McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S: Monocyte activation in alcoholic liver disease. Alcohol 2002; 27: 53-61. (Pubitemid 34626485)
45. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I: Recent advances in alcoholic liver disease. 4. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004; 287:G497-G502. (Pubitemid 39096613)
46. Deviere J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E: Excessive in vitro bacterial lipopolysaccharideinduced production of monokines in cirrhosis. Hepatology 1990; 11: 628-634. (Pubitemid 20151741)
47. Schafer C, Schips I, Landig J, Bode JC, Bode C: Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease. Z Gastroenterol 1995; 33: 503-508.
48. Tachiyama G, Sakon M, Kambayashi J, Iijima S, Tsujinaka T, Mori T: Endogenous endotoxemia in patients with liver cirrhosis-a quantitative analysis of endotoxin in portal and peripheral blood. Jpn J Surg 1988; 18: 403-408.
49. Hanck C, Glatzel M, Singer MV, Rossol S: Gene expression of TNF-receptors in peripheral blood mononuclear cells of patients with alcoholic cirrhosis. J Hepatol 2000; 32: 51-57. (Pubitemid 30039447)
50. Fukui H: Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure. Alcohol Clin Exp Res 2005; 29: 172S-179S. (Pubitemid 43194347)
51. Tanaka S, Kumashiro R, Tanikawa K: Role of the spleen in endotoxin-induced hepatic injury in chronic alcohol-fed rats. Liver 1992; 12: 306-310.
52. Muzes G, Deak G, Lang I, Gonzalez-Cabello R, Gergely P, Feher J: Depressed monocyte production of interleukin-1 and tumor necrosis factor-alpha in patients with alcoholic liver cirrhosis. Liver 1989; 9: 302-306. (Pubitemid 19249675)
53. Ledesma CF, Echevarria VS, Lozano Polo JL, Oloriz RR, Alvarez MC, Pons RF: Interleukin-1 in alcoholic cirrhosis of the liver: the influence of nutrition. Eur J Clin Nutr 1992; 46: 527-533.
54. Gosset P, Wallaert B, Canva-Delcambre V, Colombel JF, Tonnel AB: Impaired secretion and mRNA expression of monokines by alveolar macrophages from nonsmoking patients with alcoholic liver cirrhosis. J Infect Dis 1995; 171: 743-746.
55. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Deviere J: Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology 1995; 22: 1436-1439.
56. Hill DB, D'Souza NB, Lee EY, Burikhanov R, Deaciuc IV, de Villiers WJ: A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 2002; 26: 74-82. (Pubitemid 34093514)
57. Jacobi U, Bartoll J, Sterry W, Lademann J: Orally administered ethanol: transepidermal pathways and effects on the human skin barrier. Arch Dermatol Res 2005; 296: 332-338. (Pubitemid 40169527)
58. Segre JA: Epidermal barrier formation and recovery in skin disorders. J Clin Invest 2006; 116: 1150-1158.
59. Brand RM, Jendrzejewski JL, Henery EM, Charron AR: A single oral dose of ethanol can alter transdermal absorption of topically applied chemicals in rats. Toxicol Sci 2006; 92: 349-355. (Pubitemid 44018951)
60. Buono MJ: Sweat ethanol concentrations are highly correlated with co-existing blood values in humans. Exp Physiol 1999; 84: 401-404. (Pubitemid 29150028)
61. Giles HG, Meggiorini S, Renaud GE, Thiessen JJ, Vidins EI, Compton KV, Saldivia V, Orrego H, Israel Y: Ethanol vapor above skin: determination by a gas sensor instrument and relationship with plasma concentration. Alcohol Clin Exp Res 1987; 11: 249-253. (Pubitemid 18005367)
62. Farkas A, Kemeny L, Szell M, Dobozy A, Bata-Csorgo Z: Ethanol and acetone stimulate the proliferation of HaCaT keratinocytes: the possible role of alcohol in exacerbating psoriasis. Arch Dermatol Res 2003; 295: 56-62. (Pubitemid 36791724)
63. Farkas A, Kemeny L: The alcohol metabolite acetaldehyde and psoriasis: another trigger factor? Clin Exp Dermatol 2010; 35: 923-925.
64. Cheung C, Smith CK, Hoog JO, Hotchkiss SA: Expression and localization of human alcohol and aldehyde dehydrogenase enzymes in skin. Biochem Biophys Res Commun 1999; 261: 100-107. (Pubitemid 29371625)
65. Timmons SR, Nwankwo JO, Domann FE: Acetaldehyde activates Jun/AP-1 expression and DNA binding activity in human oral keratinocytes. Oral Oncol 2002; 38: 281-290. (Pubitemid 34442550)
66. Mehic D, Bakiri L, Ghannadan M, Wagner EF, Tschachler E: Fos and jun proteins are specifically expressed during differentiation of human keratinocytes. J Invest Dermatol 2005; 124: 212-220. (Pubitemid 40100971)
67. Marcekova Z, Flaig MJ, Kekus M, Ruzicka T, Rupec RA: The potential role of c-Jun activation in patients with cutaneous lichen planus. Exp Dermatol 2010; 19: 74-80.
68. Fuchs J, Zollner TM, Kaufmann R, Podda M: Redox-modulated pathways in inflammatory skin diseases. Free Radic Biol Med 2001; 30: 337-353. (Pubitemid 32155533)
69. Young CN, Koepke JI, Terlecky LJ, Borkin MS, Boyd SL, Terlecky SR: Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol 2008; 128: 2606-2614.
70. Bhatty M, Pruett SB, Swiatlo E, Nanduri B: Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses. Alcohol 2011; 45: 523-539.
71. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG: Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995; 108: 218-224.
72. Naveau S, Chollet-Martin S, Dharancy S, Mathurin P, Jouet P, Piquet MA, Davion T, Oberti F, Broet P, Emilie D: A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004; 39: 1390-1397. (Pubitemid 38569061)
73. Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, Aqel B, Boardman L, Gores GJ, Harmsen WS, McClain CJ, Kamath PS, Shah VH: A randomized, double-blinded, placebocontrolled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 2008; 135: 1953-1960.
74. Menon KV, Stadheim L, Kamath PS, Wiesner RH, Gores GJ, Peine CJ, Shah V: A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol 2004; 99: 255-260. (Pubitemid 38279865)